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Abstract
Background: Short tandem repeat polymorphisms (STRPs) are powerful tools for gene mapping
and other applications. A STRP genome scan of 10 cM is usually adequate for mapping single gene
disorders. However mapping studies involving genetically complex disorders and especially
association (linkage disequilibrium) often require higher STRP density.
Results: We report the development of two separate 10 cM human STRP Screening Sets (Sets 12
and 52) which span all chromosomes. When combined, the two Sets contain a total of 782 STRPs,
with average STRP spacing of 4.8 cM, average heterozygosity of 0.72, and total sex-average
coverage of 3535 cM. The current Sets are comprised almost entirely of STRPs based on tri- and
tetranucleotide repeats. We also report correction of primer sequences for many STRPs used in
previous Screening Sets. Detailed information for the new Screening Sets is available from our web
site: http://research.marshfieldclinic.org/genetics.
Conclusion: Our new human STRP Screening Sets will improve the quality and cost effectiveness
of genotyping for gene mapping and other applications.
Background
Since their discovery in 1988, multiallelic short tandem
repeat polymorphisms (STRPs) (also called microsatel-
lites or simple sequence length polymorphisms (SSLPs))
have been the polymorphisms of choice for linkage map-
ping and many other genetic studies.
Although there are hundreds of thousands of reasonably
informative STRPs in the human genome [1,2], only a
small fraction are optimal for genotyping and genome
scans. Optimal properties of an STRP include: high heter-
ozygosity, strong and specific PCR amplification, capabil-
ity to be amplified simultaneously with other STRPs
(multiplexed), sharp bands on gels, easy and accurate
scoring of allele sizes, relatively low mutation rate, and
appropriate position along the genetic map.
We have performed human genome polymorphism scans
in our lab since 1989 [3]. Our first human Screening Set
of STRPs developed in 1992 had an average STRP spacing
of ~20 cM, no sex chromosome STRPs, and consisted al-
most entirely of dinucleotide repeat STRPs identified at
Marshfield. Each subsequent Screening Set from our lab
improved on the previous version by adding STRPs, by us-
ing more accurate genetic maps to make STRP spacing
more uniform and to eliminate large gaps, and especially
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by replacing relatively low quality STRPs with superior
ones. Typing better STRPs leads to higher data quality
through fewer missing genotypes and fewer incorrect al-
lele calls. Typing optimal STRPs also leads to lower geno-
typing costs by providing more information, by reducing
the need for duplicate genotyping, by permitting the use
of shorter gels (with lower resolving power but shorter run
times), and by increasing the efficiency of allele calling.
We have replaced nearly all of the dinucleotide repeat
STRPs in our Screening Sets with tri- and tetranucleotide
STRPs. Although dinucleotide STRPs are abundant and
meet many of the criteria for optimal STRPs, they are also
in our hands more difficult to score accurately because of
substantial strand slippage during PCR [4]. We also find
that dinucleotide STRPs are more difficult to PCR multi-
plex than tri- or tetranucleotide STRPs.
Similarly, we have eliminated nearly all of the STRPs with
frequent (> 2%) "non-integer" alleles. Non-integer alleles
are defined as have length differences from the most fre-
quent alleles which are other than integer multiples of the
repeat length. For example, an allele of 221 bp (PCR prod-
uct length) would be a non-integer allele for a tetranucle-
otide STRP with frequent alleles of 230, 226, 222, and 214
bp. Non-integer alleles are not typing artifacts as they have
been observed in many labs and have been confirmed by
sequencing of individual alleles [5]http://
www.cstl.nist.gov/biotech/strbase. Non-integer alleles
probably exist somewhere in the human population for
all or nearly all STRPs, but a significant fraction of STRPs
do not have frequent non-integer alleles.
We have also excluded or repaired STRPs with weak or
null alleles. In at least most cases, weak and null alleles ap-
pear to be due to substitution polymorphisms within the
primer annealing sites [6]. They can be repaired by sliding
the offending PCR primer to a nearby position along the
chromosome.
For most applications of genome polymorphism scans,
higher STRP densities are preferable. This is particularly
important for gene mapping by association. While ana-
lysts have predicted that very high polymorphism densi-
ties will be required for association mapping in mixed or
outbred populations [see for example reference [7]],
promising results have been obtained using genome scans
of 600–1200 STRPs in isolated populations where levels
of linkage disequilibrium are particularly high [8–10]. In
this manuscript we describe the development of two new
10 cM human STRP Screening Sets (Sets 12 and 52) which
when combined provide average STRP spacing of 4.8 cM.
Results
Building new human Screening Sets
Over about the last decade we have produced at Marsh-
field twelve separate, but related 10 cM Screening Sets of
STRPs for the human genome (see Table 1 and http://re-
search.marshfieldclinic.org/genetics). For each of these
Sets, the lowest quality STRPs in the previous Set were re-
placed with superior ones. Of the most recent collections,
Sets 6, 7, 10, and 11 were major overhauls, with 21–52%
of the STRPs replaced (Table 1). Sets 5 and 8 were de-
scribed in the literature [11,12]. Beginning particularly
with Set 6, many of the dinucleotide STRPs were replaced
with tri- and tetranucleotide STRPs from the Cooperative
Human Linkage Center (CHLC) [13]. CHLC STRPs still
comprise 81% and 55% of our current Sets (Sets 12 and
52, respectively). Starting in about 2001, the availability
of the human genomic draft sequence greatly expanded
the number of STRPs from which to choose. Sets 12 and
52 contain 15% and 44%, respectively, newly derived
STRPs from the genomic sequence.
Table 1: History of Marshfield 10 cM STRP Screening Sets
Set Year Number of STRPs Number of Dinucleotide 
STRPs (Fraction)
Number of STRPs Shared 
with Previous Set (Fraction)
1 1992 231 211 (0.91)
2 1993 366 347 (0.95) 131 (0.36)
3 1993 319 226 (0.71) 176 (0.55)
4 1994 347 243 (0.70) 274 (0.79)
5 1994 363 191 (0.53) 265 (0.73)
6 1995 391 55 (0.14) 186 (0.48)
7 1995 390 47 (0.12) 297 (0.76)
8 1996 387 43 (0.11) 377 (0.97)
9 1997 387 44 (0.11) 378 (0.98)
10 1999 405 49 (0.12) 313 (0.77)
11 2001 410 2 (0.01) 324 (0.79)
12 2002 408 3 (0.01) 405 (0.99)BMC Genomics 2003, 4 http://www.biomedcentral.com/1471-2164/4/6
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We began the construction of Sets 12 and 52 with specific
goals. For Set 12 (and the very similar Set 11), we intend-
ed to replace all or nearly all dinucleotide repeat polymor-
phisms and to eliminate other problematic STRPs such as
those with frequent non-integer alleles. For Set 52 (and
the preceding Set 51), we aimed to identify one or two
high quality tri- or tetranucleotide STRPs at approximately
the midpoint between each pair of STRPs within Set 12.
Set 52 is therefore the second in a new series of 10 cM
Screening Sets. For both Sets, we needed to identify new,
high quality STRPs within specific, relatively small (~1
mb) chromosomal segments.
Altogether, we screened 2262 STRPs for possible inclusion
within the Screening Sets. Of these, 1103 were STRPs de-
veloped within the CHLC or at Utah [14]. The remaining
1159 were developed from human genomic sequences.
Most of these (961) were identified by searching for tri- or
tetranucleotide STRs with ≥ 7 or 8 uninterrupted repeats
within the sequence assembly available from the Univer-
sity of California – Santa Cruz web site, December 2000
version http://genome.cse.ucsc.edu. Others (198) were
identified by examining a collection of ~1 gb of overlap-
ping BAC sequences [15] for the presence of variable tri-
and tetranucleotide STRs. We focused efforts on AAT and
AGAT repeats because these sequences are known to be
abundant and to yield useful polymorphisms [13,16].
New PCR primers selected from the sequences flanking
the tandem repeats were tested by amplification with ten
individual DNA samples and one DNA pool using incor-
poration of a nucleotide tagged with a fluorescent dye (see
Methods). PCR primers labelled with a fluorescent dye at
the 5' end were then synthesized for those STRPs which
displayed ≥ 4 alleles in the first screen. These were com-
bined with existing CHLC and Utah STRPs, and were used
to screen 12 individuals and one pool. All donors of DNA
samples used in these first two screens had Northern Eu-
ropean ancestry. STRPs which passed these first two hur-
d l e s  w e r e  t h e n  u s e d  i n  g e n o m e  s c a n s  w i t h i n  t h e
Mammalian Genotyping Service (see Marshfield web site)
using hundreds of DNA samples from various geographi-
cal locations.
Only 11% of the 2262 genomic STR sequences that were
screened were included within Sets 12 and 52. The great
majority of excluded STRPs were rejected because of lim-
ited numbers of alleles (low informativeness). About 9%
were rejected because of the presence of frequent non-in-
teger alleles. We found that use of candidate genomic se-
quences with larger numbers of uninterrupted tandem
repeats and use of overlapping BAC sequences with alleles
which differed by two or more repeats led to higher rates of
STRP inclusion into the Screening Sets. Information on all
of the STRPs that we found to be polymorphic can be ob-
tained from the comprehensive list of indel polymor-
phisms on the Marshfield web site.
We also improved the amplification efficiency of Screen-
ing Set STRPs. Most of the human STRPs developed in the
early and mid 90s were based on relatively crude, single-
pass sequencing of genomic DNA subclones. Comparison
of the PCR primer sequences for Set 10 STRPs with the
new public genomic sequences revealed that a surprising-
ly high 25% of the STRPs had mismatches in at least one
of the primers (an example is shown in Figure 1). Nearly
all of the mismatches were near the middle or 5' ends of
the primers. New primers designed using the public ge-
nomic sequences were then tested side by side with old
primers. At 55°C annealing temperature and no PCR mul-
tiplexing, few differences were observed between the old
and new primer pairs, but under more stringent condi-
tions (60°C annealing temperatures), 79 STRPs were
found to amplify better with the new primer pairs (two ex-
amples are shown in Figure 2).
STRPs alleles are usually identified and labelled as the
length of the PCR product as measured on denaturing
polyacrylamide gels. Only in a handful of cases have the
full spectrum of STRP alleles been sequenced. Therefore,
STRP alleles are referenced to allele sizes for standard
DNA templates (we use the parents of CEPH family 1331
available from the NIGMS Human Genetic Cell Reposi-
tory). Allele sizes will also, of course, often change if the
PCR primer sequences for a polymorphism are altered. To
avoid null and weak alleles, to prevent the formation of
doublet bands during PCR [17,18], and to achieve opti-
mal PCR product length, we have modified original prim-
er sequences for a substantial fraction of our Screening Set
STRPs. We have used several different letters following the
STRP name to indicate changes in PCR primers (see
Marshfield web site). As two examples for STRPs on chro-
mosome 1 in Set 12: GATA26G09N indicates that one of
the original primers for GATA26G09 was changed to cor-
rect a sequencing error without change in allele sizes, and
GGAA3A07Z indicates that one of the primers for
GGAA3A07 was shifted along the chromosome resulting
in different allele sizes. Current PCR primer sequences for
all Screening Set STRPs are listed on the Marshfield web
site along with allele sizes for individuals 133101 and
133102.
Genetic Map Positions
Initially, new STRPs were selected and incorporated into
our Screening Sets based on physical distances obtained
from the December 2000 UC-Santa Cruz draft sequence
assembly. However, we soon found that the draft assem-
bly contained many errors [see for example reference [19]]
and resulted therefore in many STRPs being in the wrong
map positions. To correct these mistakes, we utilized theBMC Genomics 2003, 4 http://www.biomedcentral.com/1471-2164/4/6
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Figure 1
Correction of PCR Primer Sequences using Genomic Sequence Assemblies. The original single pass sequence for 
GATA87E02 is aligned with the sequences from several BACs containing overlapping genomic DNA. The original reverse PCR 
primer mismatched the BAC sequences near its 3' end. Note that because the great majority of the public human genomic 
sequence was generated from BAC libraries prepared from just a few donors, it is possible that two or even all three of the 
BAC sequences shown in the figure came from the same chromosome.
Figure 2
Comparison of PCR Amplification using Original and Corrected PCR Primer Sequences. Shown are electro-
phoretic separations of DNA fragments from unrelated individuals amplified at 60°C annealing temperature. Fragments 
obtained with the corrected PCR primer pairs are indicated by the N suffixes after the STRP names.BMC Genomics 2003, 4 http://www.biomedcentral.com/1471-2164/4/6
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most recent (June 2002) sequence assembly in addition to
linkage analysis using three large Sets of families. In all
cases except one (4ptel04), the linkage results matched
the June 2002 assembly in terms of STRP order (we as-
sumed the linkage results were correct for 4ptel04). Our
confidence in STRP order is therefore high.
With one exception on chromosome 6p (see below) ge-
netic map positions for the Screening Set STRPs were tak-
en from the most recent Marshfield map [20] or by
interpolation using the Marshfield map and the genetic
and physical map positions described in the previous par-
agraph. Although the new Iceland genetic map [19] is
higher resolution than the Marshfield map, a large frac-
tion (62%) of the Screening Set 12 and 52 STRPs were not
typed in the Iceland families. We did, however, check
STRP order for all STRPs that were typed in the Iceland
families and found no disagreements with the Marshfield
map, except for two close (~1 mb apart), adjacent STRPs
on chromosome 6p, ATA50C05 and ATC4D09, where the
linkage results, the Iceland map and the June 2002 se-
quence assembly all disagreed with the Marshfield map.
Characterization of Sets 12 and 52
Numbers of STRPs, heterozygosity values, and sex-average
genetic map properties for Screening Sets 12, 52, and 12
plus 52 combined, broken down by chromosome, are dis-
played in Table 2. Of the 39 total X chromosome STRPs in
the combined Sets, 3 (GATA2A12, GGAT3F08, and
GATA42G01) are in the pter pseudoautosomal region,
and 1 (SDF1) is in the qter pseudoautosomal region. The
9 Y chromosome STRPs are all male-specific. Also, two
small, tightly-spaced clusters of STRPs are included in Set
12 (six STRPs near the centromere of chromosome 11 and
three STRPs on the short arm of chromosome 1) for the
purpose of gauging linkage disequilibrium.
Table 2: General Properties of Sets 12 and 52 by Chromosome.




Chr. Set 12 Set 52 Both 
Sets
Set 12 Set 52 Both 
Sets
Set 12 Set 52 Both 
Sets
Set 12 Set 52 Both 
Sets
1 31 36 67 0.76 0.68 0.72 274.6 261.1 282.9 9.2 7.5 4.3
2 28 28 56 0.78 0.66 0.72 266.2 215.7 266.2 9.9 8.0 4.8
3 25 24 49 0.75 0.73 0.74 222.5 207.1 222.5 9.3 9.0 4.6
4 23 16 39 0.76 0.69 0.73 208.0 198.6 208.0 9.5 13.2 5.5
5 20 25 45 0.78 0.66 0.71 196.6 190.3 197.5 10.3 7.9 4.5
6 23 18 41 0.75 0.69 0.72 192.4 188.0 192.4 8.7 11.1 4.8
7 21 20 41 0.76 0.68 0.72 178.6 157.3 178.6 8.9 8.3 4.5
8 19 12 31 0.74 0.67 0.72 159.7 141.5 159.7 8.9 12.9 5.3
9 18 17 35 0.74 0.67 0.71 158.2 151.8 158.2 9.3 9.5 4.7
10 20 18 38 0.75 0.66 0.71 163.1 152.3 163.1 8.6 9.0 4.4
11 20 12 32 0.78 0.65 0.73 145.5 127.7 145.5 7.7 11.6 4.7
12 17 19 36 0.79 0.72 0.75 161.5 151.4 165.8 10.1 8.4 4.7
13 12 12 24 0.75 0.69 0.72 98.9 94.3 102.0 9.0 8.6 4.4
14 14 14 28 0.75 0.69 0.72 122.5 109.4 122.5 9.4 8.4 4.5
15 13 9 22 0.76 0.71 0.74 114.8 81.5 114.8 9.6 10.2 5.5
16 15 13 28 0.75 0.67 0.71 127.7 114.5 127.7 9.1 9.5 4.7
17 13 13 26 0.76 0.65 0.71 118.5 103.6 118.5 9.9 8.6 4.7
18 13 14 27 0.78 0.69 0.74 113.2 121.0 121.0 9.4 9.3 4.7
19 1 0 8 1 8 0 . 7 70 . 6 50 . 7 29 1 . 28 6 . 69 1 . 21 0 . 11 2 . 4 5 . 4
20 11 12 23 0.78 0.69 0.73 98.4 85.1 98.4 9.8 7.7 4.5
21 6 5 11 0.82 0.62 0.73 44.8 49.6 54.8 9.0 12.4 5.5
22 8 9 17 0.75 0.71 0.73 59.4 44.6 59.4 8.5 5.6 3.7
X 22 17 39 0.70 0.62 0.66 184.0 149.1 184.0 8.8 9.3 4.8
Y 6 3 9 0.66 0.41 0.58
Total STRPs Average Heterozygosity Total Coverage (cM) Average Spacing (cM)
408 374 782 0.76 0.67 0.72 3500 3182 3535 9.3 9.5 4.8
Genetic distances for the autosomes are sex-average, and for the X chromosome are female (except for pseudoautosomal regions).BMC Genomics 2003, 4 http://www.biomedcentral.com/1471-2164/4/6
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Set 12 STRPs with overall average heterozygosity of 76%
are more informative than Set 52 STRPs with overall aver-
age heterozygosity of 67%. At least part of this difference
may simply be a reflection of the populations used to de-
duce these values (see Methods). As shown in Table 2, X
and especially Y chromosome STRPs had lower average
informativeness than autosomal STRPs.
The average, sex-average STRP spacing of the combined
Sets was 4.8 cM. The maximum gaps are 18.4, 37.5, and
15.5 cM for Set 12, Set 52 and Sets 12 and 52 combined,
respectively. There were 13 gaps ≥ 15 cM in Set 12, 51 such
gaps in Set 52, and 29 gaps ≥ 10 cM in Sets 12 and 52 com-
bined. Set 12 STRPs were generally closer to telomeres
than Set 52 STRPs, resulting in greater total chromosomal
coverage.
A summary of repeat length in the Screening Set STRPs is
presented in Table 3. Only 3 dinucleotide STRPs remain in
Set 12. Fourteen pentanucleotide STRPs were also includ-
ed in the combined Sets.
Breakdown of the Screening Set STRPs by repeat type is
shown in Table 4. STRPs with AGAT and AAT repeats to-
gether accounted for 83% of the STRPs in the combined
Sets. Note that because of permutation and the comple-
mentary strand there are several names for each repeat
type. As just one example, AGAT repeats can also be pre-
sented as GATA, ATAG, TAGA, ATCT, TATC, CTAT, and
TCTA repeats. Following the suggestion of Jin et al. [21]
we have chosen the alphabetically minimal name.
We found that AAT repeats in particular, have a relatively
low level of non-integer alleles. For example, within Set
10, 11.1% of GGAA and 10.2% of AGAT STRPs had fre-
quent non-integer alleles, compared to only 1.8% of AAT
STRPs. Because of high rates of non-integer alleles, STRPs
with purines on one strand and pyrimidines on the other
(eg AAGG) were avoided even though they are reasonably
abundant and often especially informative [13].
Association of Screening Set STRPs with interspersed re-
peat elements (IREs) is shown in Table 5. STRPs were con-
sidered to be associated with IREs if the IRE fell in the 50
bp flanking the STR on either side (total of 100 bp of
flanking sequence). Although total numbers for some of
the STR types are relatively small, it appears that each type
of STR has its own particular signature of IRE association.
For example, AAAT STRs are very often (86%) associated
with Alu elements, consistent with the hypothesis that
most of these repeats evolved from the polyA tail of Alus
[22]. An unexpectedly large fraction of AGAT STRs (16%)
were found to be associated with LTRs. The results in Ta-
ble 5 may generally provide clues about the evolution of
STRs.
Discussion
Development of human STRP Screening Sets has paral-
leled advances in construction of genetic and physical
maps. Except in regions with long inversion polymor-
phisms [23], it should soon be possible to specify STRP or-
der within Screening Sets with near certainty. However,
because of individual and even possibly population
differences in recombination rates [24–26], it may never
be possible to specify genetic distances  between STRPs
with high precision.
Table 3: Breakdown of Screening Set STRPs by Repeat Length
Total STRPs Dinucleotide Trinucleotide Tetranucleotide Pentanucleotide
Set 12 408 3 82 318 5
Set 52 374 0 98 267 9
Both Sets 782 3 180 585 14
Table 4: Breakdown of Screening Set STRPs by Repeat Sequence.
Total STRPs AAAT AAGG AAT AATG AGAT Other
Set 12 408 13 27 78 4 265 21
Set 52 374 22 11 85 6 218 32
B o t h  S e t s7 8 23 5 3 81 6 31 04 8 35 3
Repeat sequences are listed in their alphabetically minimal forms.BMC Genomics 2003, 4 http://www.biomedcentral.com/1471-2164/4/6
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Screening Set 10 STRPs have been typed in the ~1000
members of the Human Diversity Panel [27]. We hope to
also type the new Set 12 and 52 STRPs through this Panel
in the relatively near future. It is beneficial to have a global
perspective on informativeness and allele frequencies for
each Screening Set STRP. Although the Screening Set
STRPs were initially screened using European DNA sam-
ples, we have found that in almost all cases, they are high-
ly or modestly informative in other human populations.
Consistent with previous results [28–30], average hetero-
zygosities for the Screening Set STRPs in Sub-Saharan Af-
ricans are the highest [27]. Isolated European populations
such as Sardinian villagers, and Old Order Amish in the
U.S. have only slightly diminished heterozygosities. Al-
though some Screening Set STRPs have reduced informa-
tiveness in East Asian populations such as Han Chinese,
average heterozygosities in East Asians are also only slight-
ly diminished compared to Europeans. So far, only Native
American and some Oceanic populations have average
heterozygosities for Screening Set STRPs that are substan-
tially reduced. With enough effort, it probably would be
possible to develop Screening Set STRPs with higher aver-
age heterozygosities for populations such as Native
Americans, but the practicality of such an undertaking is
uncertain.
Similarly, it would also be helpful to carry out extensive
sequencing of at least the frequent alleles for each Screen-
ing Set STRP. This would eliminate the need to approxi-
mate allele sizes. However, this would also be a large and
expensive project, and may have to wait until sequencing
costs drop so that many human genomes from around the
world can be sequenced.
Although nearly all Screening Set STRPs are at least mod-
estly polymorphic in all human populations examined to
date, this does not guarantee that they will be free of fre-
quent non-integer alleles or weak or null alleles in some
populations. For example, we have observed apparent
null alleles for some STRPs in Chinese that were not
present in Europeans (eg GATA29A01 on chromosome 6
and GGAA20G04 on chromosome 2). We have also ob-
served non-integer alleles in Sub-Saharan Africans that
have not been seen at appreciable frequency in other pop-
ulations (eg GATA104 on chromosome 7 and
GATA11A06 on chromosome 18).
Despite having much higher mutation rates than diallelic
polymorphisms, there is abundant evidence that highly
informative STRPs of the type found within Screening Sets
are generally powerful markers for detection of linkage
disequilibrium [eg [31,32]]. It is unclear, however, wheth-
er dinucleotide or tetranucleotide STRPs are superior in
this regard. Experimental evidence seems to favour higher
average mutations rates for tetranucleotide STRPs [33],
while theoretical results favour higher average rates for di-
nucleotide STRPs [34]. Analysis of STRPs typed in CEPH
reference families for construction of human genetic maps
revealed that the fraction of dinucleotide/dinucleotide
STRP pairs < 200 kb apart with linkage disequilibrium at
p < 0.01 was 18.7%, whereas the fraction for dinucle-
otide/tetranucleotide pairs was 7.9% and for dinucle-
otide/trinucleotide pairs was 22.1% (Broman K, Weber J
unpublished results).
Many of the Set 12 and 52 STRPs are superior to the thir-
teen STRPs used routinely in forensic DNA testing in the
U.S. http://www.cstl.nist.gov/biotech/strbase/fbi-
core.htm. Several of the thirteen forensic STRPs have fre-
Table 5: Association of Interspersed Repetitive Elements with Selected STR Types.
Number of STRPs Associated with Indicated Repeats (Fraction STRPs)
Repeat Total STRPs AAAT AAGG AAT AATG AGAT Other
ALU 189 (0.24) 31 (0.89) 9 (0.24) 64 (0.39) 2 (0.20) 63 (0.13) 20 (0.38)
L1 96 (0.12) 2 (0.06) 5 (0.13) 42 (0.26) 0 (0.00) 40 (0.08) 7 (0.13)
LTR 119 (0.15) 4 (0.11) 3 (0.08) 14 (0.09) 0 (0.00) 97 (0.20) 1 (0.02)
L2 16 (0.02) 1 (0.03) 1 (0.03) 4 (0.02) 4 (0.40) 4 (0.01) 2 (0.04)
MER 27 (0.03) 0 (0.00) 0 (0.00) 5 (0.03) 0 (0.00) 20 (0.04) 2 (0.04)
MIR 22 (0.03) 1 (0.03) 0 (0.00) 8 (0.05) 0 (0.00) 8 (0.02) 5 (0.10)
Other 6 (0.01) 0 (0.00) 0 (0.00) 2 (0.01) 0 (0.00) 3 (0.01) 1 (0.02)
Not Associated 352 (0.45) 3 (0.09) 23 (0.61) 44 (0.27) 5 (0.50) 259 (0.54) 18 (0.35)
TOTAL 
TESTED
7 8 13 5 3 81 6 31 04 8 35 2
STRPs were screened using Repeat Masker for IREs that are within 50 bp in either direction of the short tandem repeats (excluding the tandem 
repeats). Sums of the numbers in the columns do not match the totals because some sequences had two different interspersed repeats within the 
100 bp.BMC Genomics 2003, 4 http://www.biomedcentral.com/1471-2164/4/6
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quent non-integer alleles. Several are not especially
informative. Five of the thirteen forensic STRPs are cur-
rently included within Set 12. This occurred by chance
rather than design. If genome polymorphism scans for ei-
ther research or clinical purposes become widespread,
then overlap between our Screening Sets and forensic Sets
will have to be carefully considered.
Although our newest Screening Sets are substantial im-
provements over previous versions, they are still not per-
fect. Some STRPs have lower informativeness than
desired, and some large gaps in coverage remain. The Set
12 STRPs are generally superior to Set 52 polymorphisms
because Set 52 is new. There has not yet been a chance to
make many replacements.
We will continue to make improvements in our human
STRP Screening Sets and to post upgrades on the Marsh-
field web site. But are there limits to the quality of STRP
Sets? The answer is undoubtedly yes. There are only ap-
proximately 65,000 modestly to highly informative tri-
and tetranucleotide STRPs in the human gene pool [1,2].
Within some ~1 mb regions of the genome, we have al-
ready exhausted all likely tri- and tetranucleotide STRP
candidates. Only a small fraction (11%) of the new STRPs
we screened from the genomic sequence were selected for
the new Sets. It is quite conceivable, that over the next dec-
ade or two we will characterize all human STRPs that have
reasonable informativeness. Resequencing different hu-
man genomes will undoubtedly contribute much to this
effort.
Quite a few investigators have speculated that diallelic
polymorphisms such as SNPs or diallelic indels will sup-
plant STRPs in human Screening Sets. Our position con-
tinues to be that this question will likely be ultimately
determined by typing costs [4]. STRPs provide much more
information than diallelic polymorphisms, so diallelic
typing costs would need to drop well below those for
STRPs. This might happen, but it hasn't yet, and it's not
clear that it ever will. There may also be advantages to in-
cluding both high and low mutation rate polymorphisms
within Screening Sets (ie STRPs and diallelics) [35]. In any
case, we believe that our STRP Screening Sets will continue
to be highly valuable and widely used for many years.
Conclusions
The development of Screening Sets 12 and 52 will im-
prove gene mapping in general, and specifically genome
scans where a relatively high STRP density is required.
Complete information on all of our Screening Sets is free-
ly available from the Marshfield web site http://re-
search.marshfieldclinic.org/genetics along with lists of
over 200,000 candidate and confirmed human indel pol-
ymorphisms, both multi- and diallelic. We plan to contin-
ue to improve our human STRP Screening Sets until we
have exhausted all available STRPs at specific chromo-
somal sites.
Materials and Methods
Identification of candidate polymorphisms
Two different approaches were used to search for new pol-
ymorphisms. One approach was to use overlapping BAC
genomic sequences to select polymorphisms that varied
by more than two repeats [15]. The other approach was to
browse the genome for STRs using the December 12, 2000
version of the genomic sequence at University of Califor-
nia – Santa Cruz http://genome.ucsc.edu/[36].
Once a sequence containing the desired polymorphism
was selected (usually 400–700 bp in length), it was run
through the Repeat Masker program http://ftp.ge-
nome.washington.edu/cgi-bin/RepeatMasker in order to
avoid selecting PCR primers within Alu, L1, or other re-
peats. The Primer 3 program http://www-ge-
nome.wi.mit.edu/cgi-bin/primer/primer3_www.cgi was
used to select PCR primers. Candidate sequences which
did not permit the placement of at least one PCR primer
within unique sequence (ie outside of a repeat identified
by Repeat Masker) were not tested further. In cases where
one PCR primer was located within a repeat, the primer
from within the unique sequence was tagged with a fluo-
rescent dye.
Sequence Alignments
All of the 406 single read STRP sequences from Set 10
were Blasted against genomic sequences from the public
labs. For nearly all STRPs, we identified 1 to 3 BACs that
showed high homology (Blast criteria were score (bits) >
200, expect (E) value < e-50, and ratio of matched bases
to STRP sequence length >85%). Two different multiple
alignment programs were then used to align the single




Screening of candidate polymorphisms
For initial screening of the PCR primers, we incorporated
a dye-labelled nucleotide with a two-step PCR protocol.
Briefly, the first step contained 10 mM Tris-HCl (pH 8.3),
50 mM KCl, 1.5 mM MgCl2, 0.001% gelatin, 250 µM each
dNTP, 4.7 µM of the forward and reverse primers, 0.15
units of Taq polymerase (Roche) in a total 5 µl reaction
volume. The second reaction had the same components
and volume as in the first step, except that the forward
primer was present at 6.2 µM and R6G dUTP (Applied Bi-
osystems) at 0.5 µM with no reverse primer. About 0.5 µl
of step 1 PCR product was used as a DNA template for step
2 PCR. Each PCR step initiated with a 95°C soak for 4BMC Genomics 2003, 4 http://www.biomedcentral.com/1471-2164/4/6
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min, followed by 30 and 25 cycles for steps 1 and 2,
respectively, consisting of 95°C for 40 sec, 55°C for 75
sec, 72°C for 40 sec, and a final extension of 7 min at
72°C. An equal volume of loading solution composed of
EDTA (10 mM) and Orange G dye (13.6 mM) (Sigma)
dissolved in formamide was added to the reaction follow-
ing PCR, and 0.6 µl of the product was fractionated on de-
naturing acrylamide gels (6.0% acrylamide, 7.7 M urea,
89 mM Tris, 89 mM borate, 2.5 mM EDTA, pH 8.3).
For use of fluorescent-labelled primers, 45 ng of template
DNA is dried in the wells of 96 well polypropylene plates.
PCR amplifications were carried out in a 4 µl volume con-
taining 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 1.5 mM
MgCl2, 0.001% gelatin, 100 µM each dNTP, 0.075 µM of
fluorescent-labelled forward and unlabeled reverse prim-
er, and a 0.12 units of Taq polymerase. PCR amplification
was carried out for 27 cycles with the same times and tem-
peratures as listed above.
Genetic map positions for new STRPs
Genetic distances for the new STRPs were obtained by typ-
ing the STRPs in several projects with large numbers of Eu-
ropean families. The CRIMAP program was used to order
the STRPs and to deduce genetic distances. In order to fit
new STRPs into the Marshfield map [20], approximate ge-
netic values were obtained by extrapolations using the
new sex-average genetic distances and the Marshfield map
genetic distances for two flanking, older STRPs. In rare in-
stances, when no neighbouring STRPs with known Marsh-
field map distances were available, the genetic distances
were extrapolated from physical distances from the UC-
Santa Cruz sequence assembly, June 2002 version. For the
X-chromosome analysis, female genetic distances were
used in place of sex-average genetic distances.
Heterozygosity values were determined by typing STRPs
in two different population groups. For Cooperative Hu-
man Linkage Center (CHLC) and Utah STRPs in Set 12,
heterozygosity values were deduced by typing the STRPs
through several populations of different ethnic groups
(African, Asian and European), whereas for newly devel-
oped STRPs in Set 12 and all the STRPs within Set 52
(newly developed, CHLC, and Utah STRPs), a European
population was used. Heterozygosity estimates of the Set
10 (and many Set 12) STRPs are also available from gen-
otyping of the Human Diversity Panel [see Marshfield
web site and reference [27]].
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